227 related articles for article (PubMed ID: 33464534)
1. Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3a
Moreira-de-Sá A; Gonçalves FQ; Lopes JP; Silva HB; Tomé ÂR; Cunha RA; Canas PM
Mol Neurobiol; 2021 Jun; 58(6):2543-2557. PubMed ID: 33464534
[TBL] [Abstract][Full Text] [Related]
2. Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease.
Tyebji S; Saavedra A; Canas PM; Pliassova A; Delgado-García JM; Alberch J; Cunha RA; Gruart A; Pérez-Navarro E
Neurobiol Dis; 2015 Feb; 74():41-57. PubMed ID: 25449908
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A
Nunes ACL; Carmo M; Behrenswerth A; Canas PM; Agostinho P; Cunha RA
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732120
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A
Moreira-de-Sá A; Gonçalves FQ; Lopes JP; Silva HB; Tomé ÂR; Cunha RA; Canas PM
Neurobiol Dis; 2020 Dec; 146():105137. PubMed ID: 33049319
[TBL] [Abstract][Full Text] [Related]
5. Blockade of adenosine A
Silva AC; Lemos C; Gonçalves FQ; Pliássova AV; Machado NJ; Silva HB; Canas PM; Cunha RA; Lopes JP; Agostinho P
Neurobiol Dis; 2018 Sep; 117():72-81. PubMed ID: 29859867
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A2a receptor antagonists attenuate striatal adaptations following dopamine depletion.
Peterson JD; Goldberg JA; Surmeier DJ
Neurobiol Dis; 2012 Jan; 45(1):409-16. PubMed ID: 21964253
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors.
Heck DH; Zhao Y; Roy S; LeDoux MS; Reiter LT
Hum Mol Genet; 2008 Jul; 17(14):2181-9. PubMed ID: 18413322
[TBL] [Abstract][Full Text] [Related]
8. Region-specific impairments in striatal synaptic transmission and impaired instrumental learning in a mouse model of Angelman syndrome.
Hayrapetyan V; Castro S; Sukharnikova T; Yu C; Cao X; Jiang YH; Yin HH
Eur J Neurosci; 2014 Mar; 39(6):1018-1025. PubMed ID: 24329862
[TBL] [Abstract][Full Text] [Related]
9. Blockade of adenosine A
Li XC; Hong FF; Tu YJ; Li YA; Ma CY; Yu CY; Fang L; Chen JY; Li ZL; Bao SJ; Zhang ZL; Ying HY; Gyabaah AT; Hu SY; Shao GH; Cai XH
Exp Neurol; 2022 Apr; 350():113929. PubMed ID: 34813840
[TBL] [Abstract][Full Text] [Related]
10. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
Mulherkar SA; Jana NR
Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
[TBL] [Abstract][Full Text] [Related]
11. Caffeine Reverts Memory But Not Mood Impairment in a Depression-Prone Mouse Strain with Up-Regulated Adenosine A
Machado NJ; Simões AP; Silva HB; Ardais AP; Kaster MP; Garção P; Rodrigues DI; Pochmann D; Santos AI; Araújo IM; Porciúncula LO; Tomé ÂR; Köfalvi A; Vaugeois JM; Agostinho P; El Yacoubi M; Cunha RA; Gomes CA
Mol Neurobiol; 2017 Mar; 54(2):1552-1563. PubMed ID: 26860412
[TBL] [Abstract][Full Text] [Related]
12. Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons.
Bertran-Gonzalez J; Håkansson K; Borgkvist A; Irinopoulou T; Brami-Cherrier K; Usiello A; Greengard P; Hervé D; Girault JA; Valjent E; Fisone G
Neuropsychopharmacology; 2009 Jun; 34(7):1710-20. PubMed ID: 19158668
[TBL] [Abstract][Full Text] [Related]
13. Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.
Smith KM; Browne SE; Jayaraman S; Bleickardt CJ; Hodge LM; Lis E; Yao L; Rittle SL; Innocent N; Mullins DE; Boykow G; Reynolds IJ; Hill D; Parker EM; Hodgson RA
Eur J Pharmacol; 2014 Apr; 728():31-8. PubMed ID: 24486705
[TBL] [Abstract][Full Text] [Related]
14. Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions.
Canas PM; Porciúncula LO; Simões AP; Augusto E; Silva HB; Machado NJ; Gonçalves N; Alfaro TM; Gonçalves FQ; Araújo IM; Real JI; Coelho JE; Andrade GM; Almeida RD; Chen JF; Köfalvi A; Agostinho P; Cunha RA
eNeuro; 2018; 5(6):. PubMed ID: 30627646
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model.
Bruinsma CF; Schonewille M; Gao Z; Aronica EM; Judson MC; Philpot BD; Hoebeek FE; van Woerden GM; De Zeeuw CI; Elgersma Y
J Clin Invest; 2015 Nov; 125(11):4305-15. PubMed ID: 26485287
[TBL] [Abstract][Full Text] [Related]
16. Enhanced ATP release and CD73-mediated adenosine formation sustain adenosine A
Carmo M; Gonçalves FQ; Canas PM; Oses JP; Fernandes FD; Duarte FV; Palmeira CM; Tomé AR; Agostinho P; Andrade GM; Cunha RA
Br J Pharmacol; 2019 Sep; 176(18):3666-3680. PubMed ID: 31220343
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A
Shalaby HN; Zaki HF; Ain-Shoka AAA; Mohammed RA
Mol Neurobiol; 2022 Oct; 59(10):6397-6410. PubMed ID: 35943710
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
Xu K; Di Luca DG; Orrú M; Xu Y; Chen JF; Schwarzschild MA
Neuroscience; 2016 May; 322():129-37. PubMed ID: 26905951
[TBL] [Abstract][Full Text] [Related]
19. Modulation of A₂a receptor antagonist on D₂ receptor internalization and ERK phosphorylation.
Huang L; Wu DD; Zhang L; Feng LY
Acta Pharmacol Sin; 2013 Oct; 34(10):1292-300. PubMed ID: 23933651
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
